{
    "Trade/Device Name(s)": [
        "Atellica CH Magnesium (Mg)",
        "Atellica CH Magn"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K162399",
    "Predicate Device Reference 510(k) Number(s)": [
        "K861700"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JGJ"
    ],
    "Summary Letter Date": "December 14, 2016",
    "Summary Letter Received Date": "",
    "Submission Date": "January 19, 2017",
    "Regulation Number(s)": [
        "21CFR862.1495"
    ],
    "Regulation Name(s)": [
        "Magnesium Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Magnesium"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (Lithium Heparin)",
        "Urine"
    ],
    "Specimen Container(s)": [
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Atellica CH Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Photometric assay",
        "Modified xylidyl blue reaction"
    ],
    "Methodologies": [
        "Photometric quantification"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Atellica CH Magnesium (Mg) photometric assay for quantitative magnesium measurement in serum, plasma, and urine using the Atellica CH Analyzer",
    "Indications for Use Summary": "Quantitative determination of magnesium in human serum, plasma (lithium heparin), and urine to aid in diagnosis and treatment of hypomagnesemia and hypermagnesemia",
    "fda_folder": "Clinical Chemistry"
}